EUVIMEDEUVIMED entdecken
Crossref

Long-read sequencing bridges germline and somatic variant detection: a multi-modal approach for hereditary cancer diagnostics

Behich Koyutourk, Havva Çobanoğulları, Ömer Diker, Polat Olgun, Derya Demirtaş Esmer, Salih Müjdat Balkan, Mahmut Cerkez Ergoren

Clinical and Translational Oncology · 2026

DOI: 10.1007/s12094-026-04410-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Oncology, 2026. Verfasst von Behich Koyutourk und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics Diagnostic Laboratory, Near East University Hospital, 99138, Nicosia, Cyprus. Hauptthemen laut MEDLINE: Germ-Line Mutation, High-Throughput Nucleotide Sequencing, Neoplasms. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Effective management of hereditary cancers requires the accurate detection of both germline and somatic pathogenic variants. Conventional approaches, such as liquid biopsy and short-read sequencing, are widely used but may have limitations in resolving structural variants (SVs), providing phasing information, and capturing complex genomic alterations. Oxford Nanopore Technologies (ONT) long-read sequencing enables improved characterization of SVs and phasing, providing additional insights for germline variant analysis. AIM: In this study, we implemented a multi-modal workflow in 50 cancer patients, integrating plasma-based liquid biopsy, short-read next-generation sequencing (NGS) and ONT-based germline testing. RESULTS: Somatic mutations were identified in 72% (36/50) of patients, primarily involving TP53, PIK3CA, EGFR, and KRAS. In parallel, germline sequencing revealed pathogenic or likely pathogenic variants in 60% (30/50) of patients, including alterations in BRCA2, MSH2, and CHEK2. Importantly, 10% (5/50) of patients harbored clinically actionable germline variants that were not detected by liquid biopsy, whereas 22% (11/50) showed somatic-only alterations. Notably, 18% (9/50) of patients had no detectable pathogenic variants in either analysis, potentially reflecting biological factors such as low circulating tumor DNA (ctDNA) levels or limitations in panel coverage. CONCLUSION: These findings highlight the complementary and non-redundant roles of somatic liquid biopsy and germline analyses. Rather than indicating diagnostic equivalence, the results show that each approach captures distinct but clinically relevant genomic information. The inclusion of ONT long-read sequencing may improve the characterization of inherited variants, particularly structural variants and phasing and may support more comprehensive risk assessment and therapeutic planning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Germ-Line MutationHigh-Throughput Nucleotide SequencingNeoplasmsHumansFemaleLiquid BiopsyMaleMiddle AgedCheckpoint Kinase 2Class I Phosphatidylinositol 3-KinasesAgedGenetic Predisposition to DiseaseMutationAdultBiomarkers, TumorProto-Oncogene Proteins p21(ras)ErbB ReceptorsTumor Suppressor Protein p53

Stichwörter der Autor:innen

Circulating tumor DNA (ctDNA)Germline mutationsHereditary cancer diagnosticsLong-read sequencingSomatic mutations

Substanzen

Checkpoint Kinase 2CHEK2 protein, humanClass I Phosphatidylinositol 3-KinasesPIK3CA protein, humanBiomarkers, TumorTP53 protein, humanKRAS protein, humanEGFR protein, humanProto-Oncogene Proteins p21(ras)ErbB Receptors

Autor:innen und Institutionen

  • Medical Genetics Diagnostic Laboratory, Near East University Hospital, 99138, Nicosia, Cyprus.
  • Department of Biological Sciences, Faculty of Arts and Sciences, Eastern Mediterranean University, 99628, Famagusta, Cyprus. havva.cobanogullari@emu.edu.tr.
  • Department of Biological Sciences, Faculty of Arts and Sciences, Eastern Mediterranean University, 10, Mersin, Northern Cyprus, Turkey. havva.cobanogullari@emu.edu.tr.
  • Department of Medical Oncology, Faculty of Medicine, Near East University, 99138, Nicosia, Cyprus.
  • Department of Oncology, Burhan Nalbantoğlu State Hospital, 99010, Nicosia, Cyprus.
  • Department of General Surgery, Near East University Hospital, 99138, Nicosia, Cyprus.

Zitieren

APA

Koyutourk, B., Çobanoğulları, H., Diker, Ö., Olgun, P., Esmer, D. D., Balkan, S. M., & Ergoren, M. C. (2026). Long-read sequencing bridges germline and somatic variant detection: a multi-modal approach for hereditary cancer diagnostics. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-026-04410-9

Vancouver

Koyutourk B, Çobanoğulları H, Diker Ö, Olgun P, Esmer DD, Balkan SM, et al. Long-read sequencing bridges germline and somatic variant detection: a multi-modal approach for hereditary cancer diagnostics. Clinical and Translational Oncology. 2026. doi:10.1007/s12094-026-04410-9

BibTeX
@article{Koyutourk2026,
  author = {Koyutourk, Behich and Çobanoğulları, Havva and Diker, Ömer and Olgun, Polat and Esmer, Derya Demirtaş and Balkan, Salih Müjdat and Ergoren, Mahmut Cerkez},
  title = {Long-read sequencing bridges germline and somatic variant detection: a multi-modal approach for hereditary cancer diagnostics},
  journal = {Clinical and Translational Oncology},
  year = {2026},
  doi = {10.1007/s12094-026-04410-9}
}
Kostenlos starten →